Roivant Sciences Ltd ROIV

‎$‎16.240.07(0.41%)(1D)

• Delayed prices by Nasdaq • in USD

Invest in Roivant Sciences Ltd
Today

Create an eToro account to buy ROIV stock on a secure, user-friendly, multi-asset trading platform.

Roivant Sciences Ltd ROIV

Buy ROIV

Analyst Forecast

Consensus

Strong Buy

Price Target

21.50

Based on analysts who covered ROIV

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

Bentley Systems, Incorporated

Lithium Americas Corp

More about Roivant Sciences Ltd

Roivant Sciences is a biopharmaceutical company delivering innovative health solutions worldwide. Specialising in applying technology to drug development, it aims to create transformative medicines for patients facing serious diseases.

Operational in the healthcare sector, Roivant is committed to reducing the time and cost of developing new medicines. It provides services in multiple therapeutic areas through a decentralised model, with numerous subsidiaries called ‘Vants.’ Each ‘Vant’ focuses on a different area, like neuroscience or women's health, pushing the company in numerous directions.

Stay up to date on the share price of ROIV by adding it to your eToro watchlist.

ROIV Stock Price Chart

‎28.01‎

Past Month

MAX

*Past performance is not an indication of future results

The Roivant Sciences Ltd share price is rising this week.

The Roivant Sciences Ltd share price today is ‎$‎16.24, reflecting a ‎0.41‎% change over the last 24 hours and ‎7.82‎% over the past week. The current market capitalization of ROIV is ‎$‎11.04B with an average volume in the last three months of 6.61M. The stock has a P/E ratio of -23.14 and a dividend yield of 0%. With the stock’s beta sitting at 0.84

Jump to:

About ROIV >
How to Buy? >
Top Guides >

Market Cap

‎$‎11.04B

Day’s Range

‎$‎16.22 - ‎$‎16.74

52W Range

‎$‎8.7 - ‎$‎16.74

Average Volume (3M)

6.61M

Price-Earnings Ratio

-23.14

Revenue

‎$‎23.23M

Dividend (Yield)

‎$‎0 (0%)

Prev Close

‎$‎16.17

EPS

‎$‎-0.7

Beta

0.84

What Is Roivant Sciences Ltd?

CEO

Matthew Gline

Employees

750

Founded

2014

London, Greater London, GB

Med Tech

NASDAQ

Get Started

How can I buy Roivant Sciences Ltd stocks?

To purchase Roivant Sciences Ltd:

Create an eToro account:

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.

Search and purchase:

Search the Roivant Sciences Ltd (ROIV) page and place an order to buy Roivant Sciences Ltd.

Buy ROIV

Looking for more information? Check out our guide on Academy.

Top Guides

Our top picks for the most relevant guides from the eToro Academy

Top Dividend Stocks for 2025

Gear up for 2025 with these top dividend stocks. Dive into the potential of Verizon, Exxon Mobil, NextEra, Coca Cola, Unicredit through eToro’s expert analysis.

Stock Trading And Investing For Beginners

New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.

AI Stocks Poised for Growth in 2025

Gear up for 2025 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.

Go to the Academy >

Invest in Roivant Sciences Ltd
Today

Create an eToro account to buy ROIV stock on a secure, user-friendly, multi-asset trading platform.

Get Started

FAQ

What is the current price of Roivant Sciences Ltd stock?

The current price of ROIV is ‎$‎16.24.

What is Roivant Sciences Ltd’s stock future price target?

The average price target for Roivant Sciences Ltd is ‎$‎21.50. Sign up to eToro for detailed analyst forecasts and price targets.

What are analysts’ forecasts for Roivant Sciences Ltd?

Analysts offer forecasts for Roivant Sciences Ltd based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.

What is the market cap of Roivant Sciences Ltd?

The market capitalisation of Roivant Sciences Ltd is ‎$‎11.04B

Is Roivant Sciences Ltd stock buy, sell or hold?

Based on 4 analysts offering recommendations for ROIV in the last 3 months, the overall consensus is Strong Buy.

Daily Movers

Explore the biggest stocks movers on the market.